Alpha Cognition Launches ZUNVEYL
for Mild to Moderate Alzheimer's Disease
|
Alpha Cognition Inc., a North Texas biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, has officially launched ZUNVEYL, a groundbreaking treatment for mild to moderate Alzheimer’s disease. ZUNVEYL offers a differentiated therapeutic option designed to address the unique challenges faced by individuals with Alzheimer’s, providing an alternative for those with limited treatment options. This launch marks a significant milestone in the company’s mission to provide innovative and accessible solutions for the millions affected by neurodegenerative diseases, while offering new hope to patients and caregivers.
|
Unlocking Non-Dilutive Funding: Embark on a Journey Through Government Policies with Eva Garland
|
Join Eva Garland for an exclusive webinar where she will delve into the evolving impact of government policies on the non-dilutive funding landscape, offering expert insights on how scientists and entrepreneurs can navigate these changes to secure funding.
|
Discover Waco’s Thriving Life Science Industry with BioNTX
|
Join BioNTX on April 17th for an exclusive tour of the Baylor Research and Innovation Collaborative (BRIC) and insightful panel discussions on the rapid growth of Waco’s life science industry. Don’t miss this opportunity to connect with industry leaders and explore the innovation driving the region forward!
|
Join Us Tomorrow for BIO BREAK Fort Worth:
Networking & Collaboration in Life Sciences
|
BioNTX, RSM, Haynes Boone, and UTA are excited to partner once again to host our monthly BIO BREAK at The Holly in Fort Worth. Join us tomorrow for an evening of networking, idea exchange, and meaningful connections.
This is a fantastic opportunity to engage with industry professionals from the life sciences sector, share insights, and explore potential collaborations in a dynamic and welcoming environment.
|
As North Texas continues to emerge as a powerhouse for biotech and healthcare innovation, your leadership and insights are more critical than ever. Our upcoming Second Quarterly BHIANT Meeting on April 29th is your opportunity to shape the future of our industry—ensuring we have the talent, resources, and infrastructure needed to drive growth.
This gathering is not just another meeting; it is a strategic forum where industry leaders like you will collaborate to tackle pressing workforce challenges, align on shared goals, and strengthen the biotech ecosystem across North Texas.
Your presence will make an impact, and we want your voice at the table.
If you are an industry leader or community member, please RSVP today.
|
iC³ SUMMIT NEWS & UPDATES
|
Save The Date: September 2025
|
The iC³ Life Science Summit is an event that brings together leaders and innovators from the life sciences and healthcare sectors to discuss challenges, discover new opportunities, and drive transformation.
As we look ahead to the 2025 iC³ Life Science & Healthcare Innovation Summit, we are celebrating “10 Years and Beyond” with a focus on the cutting-edge intersection of biology, technology, and artificial intelligence (AI). This convergence is powering breakthroughs in precision medicine, biomanufacturing, and other fields shaping the future of healthcare.
|
Dates
Tuesday, September 16: 7:00am - 7:00pm
Wednesday, September 17: 8:00am - 3:00pm
|
Location
Hilton Anatole
2201 N Stemmons Freeway, Dallas, TX 75207
|
Nominate a North Texas Life Sciences Leader
for the 2025 iC³ Dennis K. Stone Award
|
BioNTX honors individuals who have made significant contributions to the North Texas biotechnology industry through the Dennis K. Stone Award. This recognition celebrates those who have advanced life science research and inspired others to do the same.
Nominees should meet the following criteria:
-
Industry Growth & Innovation: Contributed to the formation and growth of multiple North Texas-based life science businesses.
- Generosity: Donated time, resources, or funds to support the North Texas life science community.
- Mentorship & Inspiration: Inspired and mentored others, fostering the continued growth of the North Texas life science industry.
-
Regional Advocacy: Actively championed the region as a thriving hub for successful life science ventures.
|
Recognizing the Next Generation of
Life Science & Healthcare Innovators
|
BioNTX is proud to spotlight emerging leaders in life sciences and healthcare innovation through the Rising Stars program at the iC³ Summit. This program honors entrepreneurs, startups, and researchers making a significant impact.
Nominees should meet the following criteria:
- Emerging entrepreneurs
- Innovative startups & early-stage companies
- Researchers driving groundbreaking advancements
- Organizations with ≤ $100M in funding or sales
|
iC³ Summit: Tech Transfer Showcase Expands in 2025
|
Are you ready to take your breakthrough to the next level? The Tech Transfer Showcase at BioNTX’s iC³ Life Science Summit is your chance to spotlight your most promising intellectual property in front of industry leaders, investors, and potential collaborators. This exclusive platform can open the door to meaningful partnerships and funding opportunities that move your innovation forward.
This year, we are expanding the spotlight! Innovators from Oklahoma, Louisiana, Arkansas, Tennessee, and New Mexico are invited to apply and join this dynamic regional showcase.
Applications open on May 1st
|
University of Texas - Tyler
Entrepreneurial Ecosystem Building
|
Join BioNTX on May 20th in Tyler, TX, for the second annual symposium focused on Building a Life Science Entrepreneurial Ecosystem. This event will highlight groundbreaking biomedical research and address crucial topics, including intellectual property, funding strategies, and entrepreneurial success. Attendees will gain valuable insights into the growth of the region’s life science industry and its role in shaping the future of healthcare and innovation.
|
BIO BREAK Dallas: Kicking Off Spring
with Networking and Innovation
|
BioNTX, McDermott Will & Emery, and Deloitte teamed up to host our monthly BIO BREAK at Pegasus Park in Dallas, TX. This event marked a great start to the Spring season, bringing together professionals, innovators, and leaders from across the life sciences sector. A key highlight this month was our focus on local incubators, showcasing the incredible work being done to support emerging biotech companies. It was an excellent opportunity to connect with like-minded individuals, exchange ideas, and build valuable relationships in a relaxed, collaborative environment.
|
The BioNTX Talent Network Career Expo & HR Forum:
Where Talent Meets Opportunity
|
(left photo) Adriana Almodova of UTSW, Andrew Klein, MBA, Spike Neuro, Leah Banks, PhD of UTSW and Cyonna Holmes, PhD of Celanese
(right photo) Kathleen Otto-Rosenblum of BioNTX, Andrew Dickhaut, Catapult Solutions Group, Amanda Bastawros of Colossal Biosciences,
Irma Croteau, MEd of Swiss American CDMO, Micaela Herndon, EdD of Dallas College and Eric Moore of BioNTX
|
The annual BioNTX Talent Network Career Expo and HR Forum is quickly becoming a signature event for North Texas’ life science and healthcare innovation ecosystem. This high-impact experience brings together industry leaders, HR professionals, students, and job seekers to ignite meaningful conversations, drive connections, and shape the future of our regional workforce.
This year, for the first time, the Career Expo and HR Forum were combined into one powerful, full-day event—creating a unique space where employers and job seekers engage directly, and where forward-thinking strategies for hiring, retention, and professional development are shared in real time.
The HR Forum equips life science employers with actionable insights into workforce management, talent acquisition, and building high-performing teams—critical tools for staying competitive in a rapidly evolving industry. Meanwhile, the Talent Network Career Expo offers job seekers expert-led guidance, networking opportunities, and direct access to potential employers, helping them confidently take the next step in their careers.
As an annual anchor event, the BioNTX Talent Network Career Expo and HR Forum will continue to strengthen our talent pipeline, fuel innovation, and ensure North Texas remains a national leader in life sciences.
Interested in monthly networking and meet-and-greet events?
|
Thank you for your support!
|
UT Dallas' UTDesign® Meet & Greet
Showcases Emerging Talent and Strategic Partnerships
|
BioNTX attended the nationally recognized UTDesign program at the Richardson IQ. The event highlighted the impact of the amazing real-world industry challenges the UTDesign Capstone program is addressing. UTD, local and national firms like Raytheon and others are cultivating a robust talent pipeline. Attendees were given a tour of the UTDesign Studio a 43,000+ square foot, state-of-the-art facility dedicated to supporting student innovation, collaboration, and applied learning throughout the Capstone experience.
|
A Tribute to Ann Tanabe at BioHouston’s Annual Chili Cook-Off
|
BioNTX attend the 2025 BioHouston Annual Chili Cook-Off—an event that brought together members of the life sciences community for a day of networking, collaboration, and, of course, great chili.
This year’s gathering featured a special tribute to Ann Tanabe, recognizing her enduring legacy and the pivotal role she played in shaping both BioHouston and the broader life sciences community. Her leadership, vision, and dedication have left a lasting impact on the region’s innovation ecosystem.
|
Translating Data Into Cures: The Adjuvant Genomics Approach
|
Adjuvant Genomics is transforming the future of healthcare through the power of precision medicine. By leveraging next-generation sequencing and advanced genomic analysis, the company helps healthcare providers uncover deeper insights into complex diseases—especially in oncology and infectious disease care.
Through cutting-edge genomic profiling and data interpretation, Adjuvant Genomics enables more personalized, targeted treatment options for patients. Their mission is simple but powerful: to bridge the gap between genomic science and clinical care, improving outcomes and empowering providers with the tools to make informed, data-driven decisions.
|
DFW Airport Named Finalist for ‘Cargo Airport of the Year’- A Testament to Innovation, Sustainability, and Global Impact
|
DFW Airport has been named a finalist for Cargo Airport of the Year in the large airport category by Air Cargo Week—a powerful recognition of the relentless drive, collaboration, and forward-thinking leadership of the DFW Cargo Community.
More than just a logistics hub, DFW is redefining what it means to move the world responsibly. As a trailblazer in sustainable aviation, DFW is setting a bold standard for green airport operations—prioritizing innovation, resiliency, and environmental stewardship across every facet of its cargo ecosystem.
With a deep commitment to precision and performance, DFW is proud to be only the second airport in North America to achieve the prestigious IATA CEIV Pharma certification. This milestone strengthens the airport’s role as a critical lifeline for life-saving pharmaceutical shipments worldwide.
Partnering with leading logistics providers, DFW has also earned the IATA Center of Excellence for Independent Validators (CEIV) certification—further showcasing its best-in-class infrastructure and unwavering commitment to safe, efficient, and sustainable cargo movement.
Now is the time to amplify this momentum. Join us in celebrating this recognition—and help us shape the future of cargo with purpose. Because at DFW, sustainability isn’t just a goal—it’s the standard.
Vote for DFW. Support a future-forward airport that’s building global connections, responsibly.
|
Morgan Stanley GIFT Cures Honored with Synergy
for Change Award for Advancing Medical Innovation
|
Morgan Stanley GIFT Cures, powered by Harrington Discovery Institute, has been honored with the prestigious Synergy for Change Award for its transformative partnership in advancing medical research and treatment. This collaboration focuses on accelerating the development of breakthrough therapies for complex diseases like Alzheimer’s, cancer, and rare conditions.
Morgan Stanley GIFT Cures is a groundbreaking program designed to bring together philanthropists, foundations, family offices, and companies committed to accelerating cures for some of the most pressing health challenges of our time.
|
Articulate Labs: Revolutionizing
Physical Therapy with Everyday Movement
|
Articulate Labs develops innovative devices that use neuromuscular electrical stimulation to help individuals rebuild strength, reduce pain, and integrate physical therapy into their daily routines. The idea for the company came from a personal struggle when one of the founders, after a traumatic accident, could not keep up with physical therapy sessions due to work and family commitments. This challenge inspired the team to create a solution that brings therapy directly to the patient. Their device allows users to turn everyday activities like walking or grocery shopping into strengthening and retraining exercises while also tracking progress to offer valuable insights for both patients and healthcare providers.
|
Lantern Pharma Reports Strong 2024 Results and Highlights Advancements in AI-Driven Oncology Drug Development
|
Lantern Pharma Inc., a clinical-stage biopharmaceutical company utilizing its RADR® AI and machine learning platform to advance oncology drug discovery, announced financial results for the fourth quarter and full year ended December 31, 2024. The company is actively enrolling patients in three clinical precision oncology programs, with significant clinical readouts expected in 2025. The Phase 2 HARMONIC™ trial for LP-300 has expanded into Japan and Taiwan, focusing on never-smoker NSCLC patients. Early Phase 2 data has shown an 86% clinical benefit rate and 43% objective response rate. Lantern plans to share more results from the expansion cohort in Q2 2025, with additional advancements in LP-300’s synergy with EGFR, ALK, MET, and RET inhibitors.
|
Nanoscope Therapeutics' Synthetic Opsin Offers Hope
for Patients with Retinal Degenerative Diseases
|
Nanoscope Therapeutics, a biotechnology company focused on developing and commercializing innovative gene therapies to restore vision in patients with retinal degenerative diseases, has announced a major breakthrough in mutation-independent optogenetic monotherapy for inherited retinal diseases. Their recent publication in Molecular Therapy highlights the successful use of a synthetic opsin to restore vision in patients with severe retinal degeneration. The engineered opsin, delivered through an optimized gene therapy vector, has shown promising results in improving visual acuity, shape discrimination, and mobility in patients with retinitis pigmentosa. This marks a significant step forward in treating these diseases, offering a potential universal treatment for retinal degenerative conditions.
|
Spark Biomedical Completes Enrollment in
Phase II Trial for NOWS Treatment
|
Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal Phase II clinical trial to explore non-invasive transcutaneous auricular neurostimulation (tAN®) therapy as a means to reduce prolonged opioid treatment for newborns with Neonatal Opioid Withdrawal Syndrome (NOWS). The study focused on infants over 33 weeks gestational age, examining how tAN therapy combined with morphine affects time to medical readiness for discharge. Participants will be monitored for two years to assess long-term neurodevelopmental outcomes.
|
Deloitte Partners with Mercans to Enhance Global
Payroll Compliance and Quality Management
|
Deloitte, one of the world’s leading professional services firms, has partnered with Mercans, a global leader in payroll and compliance solutions, to develop and implement a cutting-edge Quality Management and Risk Framework. This collaboration will strengthen Mercans' internal controls, governance, and quality assurance to ensure secure, compliant, and future-ready payroll and HR solutions for clients worldwide
|
EY Partners with NVIDIA to Launch
AI-Powered EY.ai Agentic Platform
|
Ernst & Young has unveiled its innovative EY.ai Agentic Platform, developed in collaboration with NVIDIA, designed to transform enterprise operations through AI-driven reasoning and enhanced productivity. Built on NVIDIA's full AI stack, including the new NVIDIA AI-Q Blueprint, the platform integrates domain-specific AI models with human knowledge to streamline complex compliance requirements and operational tasks across sectors like life sciences, manufacturing, and financial services.
|
RSM US LLP Named to 2025 CRN Tech Elite 250 for
Excellence in IT Solutions and Certifications
|
RSM US LLP, a leading provider of assurance, tax, and consulting services for the middle market, is proud to announce its inclusion on the 2025 CRN Tech Elite 250 list. This prestigious annual recognition highlights solution providers in the U.S. and Canada who distinguish themselves by achieving top-tier certifications and specializations from leading technology vendors. The companies selected for this list demonstrate exceptional proficiency in delivering cutting-edge IT solutions and services, with a focus on helping clients navigate the growing complexities of modern technologies.
|
UNTHSC Awarded NIH Grant to Address
Bioethical Challenges in Prosthetic Development
|
The University of North Texas Health Science Center at Fort Worth (UNTHSC) will play a pivotal role in conducting this groundbreaking research on the bioethical challenges surrounding bionic and robotic prostheses. UNTHSC, led by Assistant Professor Graci Finco, will be responsible for coordinating the study, including the centralization of data collection and the development of the decisional support document that will guide ethical research and policy decisions in prosthetic development. The university’s involvement in this project will help shape the future of prosthetic design, implementation, and policy, ultimately striving to improve the quality of life for individuals with limb loss.
|
UTA Launches Mobile Simulation Lab
to Train Rural Healthcare Workers
|
UTA has launched a cutting-edge mobile simulation lab to train healthcare workers in rural Texas, addressing a critical shortage in many of the state’s 172 rural counties. The lab features high-tech mannequins that simulate real medical conditions, including childbirth and head injuries, providing online students with hands-on training through partner hospitals. Equipped with 360-degree cameras and interactive capabilities, the lab helps students refine their skills and gain confidence. UTA’s goal is to train and retain nurses in underserved communities, ensuring better healthcare access across the state.
|
UT Dallas and CorroHealth Enhance
Medical Coding with Advanced AI
|
The University of Texas at Dallas (UTD) partnered with CorroHealth to enhance its AI-powered medical coding platform, PULSE, by integrating advanced reasoning capabilities. Unlike traditional AI models that rely solely on pattern matching, UTD researchers developed a back-end reasoning engine that mimics human logic, improving accuracy and efficiency in medical coding. This innovation allows the AI to extract and process complex health data more effectively, reducing errors and streamlining workflows. CorroHealth has already implemented the upgrade, reporting greater accuracy and significant time savings, showcasing UTD’s impact on real-world AI advancements.
|
UT Southwestern Identifies Key Protein’s Dual Role in Sepsis,
Paving Way for New Treatments
|
Researchers at UT Southwestern Medical Center have discovered how the protein angiopoietin-2 (ANGPT2) can both protect and harm blood vessels during sepsis, a leading cause of hospital deaths. Their study, published in The Journal of Clinical Investigation, reveals that while intact ANGPT2 supports anti-inflammatory functions, fragments of the protein—produced by the enzyme cathepsin K (CATK)—trigger damaging inflammation. Blocking CATK in mice improved organ function, suggesting a potential new treatment for sepsis. These findings could lead to better ways to predict, monitor, and treat the condition in human patients.
|
FUNDING & MENTORSHIP OPPORTUNITIES
|
Accelerating and Scaling Biological Sciences With AI
Application Due April 16, 2025
|
The Chan Zuckerberg Initiative (CZI) invites proposals to build large-scale AI/ML models that cannot be created with conventional university resources. CZI is the only philanthropic organization to fund and build one of the largest computing systems dedicated to nonprofit life sciences research in the world. CZI’s cluster is optimized for AI and machine learning training at scale and comprises 1,024 Nvidia H100 GPUs in an NVIDIA DGX SuperPOD configuration with access to VAST fast data storage.
This grant is for an allocation of CZI’s GPU resource (minimum request of 96 GPUs). This is an in-kind award; there are no cash funds, financial contributions, or fees of any kind associated with the award.
Applications will be accepted for consideration on the third Wednesdays of every month until June.
|
Startup Prize: Focus on Health
Application Due April 18, 2025
|
Based in Shreveport, LA, Startup Prize: Focus on Health is a national entrepreneurial competition for early-stage health, medical and life sciences startups and provides an incredible opportunity for those companies to battle test and advance their concepts with subject matter experts, payers, providers and system leaders. We thought this might be a great fit for any medical, health & wellness and healthtech startups in your program.
|
NASA Translational Research Institute for Space Health (TRISH)
Program ends May 15, 2025
|
TRISH is an applied space health research catalyst that funds disruptive, high-impact research and technologies for astronauts. TRISH partners with NASA’s Human Research Program through a consortium led by Baylor College of Medicine’s Center for Space Medicine. Through this funding opportunity, TRISH seeks projects to help provide more accurate and precise ways of performing real-time non-invasive intracranial pressure monitoring for astronauts. Proposals must include non-invasive intracranial pressure estimation techniques to benchmark against existing methods with the goal of understanding their validity. Funded projects will undergo two consecutive phases. The first phase, the “Flight Definition Phase,” will consist of preparing for a potential flight on an orbital commercial spaceflight mission. The second phase, the “Flight Implementation Phase,” will provide support before, during, and after the flight.
|
NIH Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
Program ends May 8, 2027
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions.
|
Upcoming Events & Opportunities
|
BIO BREAK: Fort Worth's Life Sciences Happy Hour
Join BioNTX, RSM, Haynes Boone and UTA for a special happy hour dedicated to the life science community—where ideas flourish, partnerships grow, and collaboration thrives. Reconnect with colleagues, spark new relationships, and toast to the shared passion that drives us forward, all in a warm and welcoming atmosphere.
April 8th | Fort Worth, TX
|
ISPE Annual Vendor Show 2025
Join the ISPE for their Annual Vendor Show 2025, which showcases the latest pharmaceutical engineering products and services, offering networking and learning opportunities.
April 9th | Montgomery, TX
|
SEC Focus on Life Sciences Industry: What To Expect and How To Get Ahead of It
Join Morgan Lewis partners and former US Securities and Exchange Commission (SEC) staff Kelly Gibson and Carolyn Welshhans as they share some of their institutional knowledge as relates to the workings and priorities of the SEC for 2025.
April 10th | Online
|
Pegasus Park Speaker Series: Insights from
the Frontlines of Health Policy
Join Pegasus Park for a panel of experts who have been on the frontlines of health policy: Dr. Amy Abernethy (Cofounder, Highlander Health), as well as former FDA Commissioners Mark McClellan and Robert Califf. The panel will be moderated by Dr. Brad Hirsch (Cofounder, Highlander Health).
April 16th | Dallas, TX
|
Life Science in Waco: A City To Believe In
Join BioNTX at the Baylor Research and Innovation Collaborative (BRIC) for an exclusive tour and panel discussions highlighting the rapid growth of Waco’s life science industry. Following the program, there will be a happy hour to celebrate Waco's expanding life science ecosystem!
April 17th | Waco, TX
|
BHIANT Q2 Meeting
Join BHIANT for their second quarterly meeting of 2025. Meet with other industry leaders and collaborate to tackle pressing challenges, redefine shared goals, and strengthen the biotech and healthcare ecosystem across North Texas.
April 29th | Bedford, TX
|
Thank you for your Membership & Support!
|
|
